|[March 06, 2013]
Elekta: Kuopio University Hospital First in Finland with Elekta's New Beam Shaping Innovation for Radiotherapy of Cancer Patients
KUOPIO, Finland --(Business Wire)--
In the spring of 2013, Kuopio University Hospital (KUH, Kuopio, Finland)
will take a leap forward in radiation therapy capabilities when the
center begins treating patients with its two new Elekta (STO:EKTAB)
Infinity™ treatment systems equipped with the revolutionary Agility™
160-leaf multileaf collimator (MLC). The two Elekta therapy systems will
replace two older generation linear accelerators from Varian Medical
"Elekta's Infinity system, with kilovoltage CBCT imaging provides very
good images of the tumor and surrounding soft tissues, which will give
us greater confidence in the location and dimensions of the tumor target
immediately before we deliver the beams," says Jan Seppälä, Ph.D.,
Medical Physicist at KUH.
In combination with Agility, the Infinity systems - specifically
designed to deliver fast Volumetric Modulated Arc Therapy (VMAT) - will
enable faster treatments tailored to the profile of the tumor. Agility
uses 160 high-speed, 5mm-wide beam-shaping leaves to accurately conform
the radiation field to the lesion's shape, and moves the leaves at twice
the speed of other MLCs.
"Agility's dose conformality and leaf speed opens up possibilities to
develop iproved treatment plans. Combined with VMAT's fast treatment
arcs, it will enable even faster beam delivery times and less time for
the patient on the therapy table," he adds.
KUH also has purchased Elekta's Oncentra® VMAT and Monaco® treatment
"Beyond the technological sophistication of this new Elekta equipment,
we are very excited to work with Elekta treatment machines, which are
uncommon in Finland," Dr. Seppälä notes.
In 2015, KUH will relocate its radiation therapy systems to a new
six-bunker radiotherapy department.
Agility is not available for sale or distribution in all regions. Please
contact your local Elekta representative or authorized distributor for
# # #
The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial
Instruments Trading Act. The information was published at 08:00 CET on
March 6, 2013.
Elekta is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The company
develops sophisticated, state-of-the-art tools and treatment planning
systems for radiation therapy, radiosurgery and brachytherapy, as well
as workflow enhancing software systems across the spectrum of cancer
care. Stretching the boundaries of science and technology, providing
intelligent and resource-efficient solutions that offer confidence to
both healthcare providers and patients, Elekta aims to improve, prolong
and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over
6,000 hospitals worldwide. Elekta employs around 3,400 employees
globally. The corporate headquarters is located in Stockholm, Sweden,
and the company is listed on the Nordic Exchange under the ticker EKTAb.
This information was brought to you by Cision http://news.cision.com
[ Back To Technology News's Homepage ]